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Background: Anaemia during pregnancy can lead to adverse maternal and perinatal outcomes. The WHO
recommends that all pregnant women in areas where anaemia is prevalent receive supplements of iron and folic acid.
However, due to many factors, the use of iron and folic acid supplementation is still low in many countries. This study
was conducted to assess the rates of iron-folic supplementation and the associated factors during pregnancy and the
effects of taking iron-folic acid supplementation on rates of maternal anaemia and low birth weight (LBW) infants.
Methods: A cross-sectional study was conducted at Khartoum Hospital, Sudan. Enrolled women answered a
questionnaire on socio-demographics characteristics, their pregnancy and delivery.
Results: Of 856 women, 788 (92.1%) used iron-folic acid supplementation during pregnancy and 65.4% used folic acid.
While place of residence, occupation and level of education were not associated with iron-folic acid usage, older age
(OR = 3, CI = 1.4–6.3) and use of antenatal care (OR = 14.3, CI = 7.4–27.5) were associated with iron-folic acid use.
Primiparity (OR = 3.8, CI = 1.9–7.6), maternal employment (OR = 3.9, CI = 2.25–6.77) and use of antenatal care (OR = 7.9,
CI = 4.1–15) were the factors associated with folic acid. Using iron-folic acid was protective against anaemia (OR = 0.39,
CI = 0.2–0.7) and LBW infants (OR = 0.3, CI = 0.17–0.68).
Conclusion: There was a high rate of iron-folic acid supplementation use among pregnant women in Khartoum,
Sudan, which was beneficial in preventing anaemia in expectant mothers and infants of LBW.
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The World Health Organization (WHO) estimates that
500 million women of reproductive age worldwide are
anaemic, and the vast majority of anaemic pregnant
women are in Africa [1,2]. Anaemia during pregnancy
(haemoglobin level less than 11 g/dl) can lead to adverse
maternal and perinatal outcomes, including maternal
and perinatal mortality [3-8].
The WHO recommends that all pregnant women in
areas where anaemia is prevalent should receive supple-
ments of iron and folic acid [5]. In spite of the WHO
recommendation, the use of iron and folic acid supple-
mentation is still low in many countries, especially in
countries with low resources [9,10]. Various factors, such
as socio-demographics and health factors, determine the* Correspondence: ishagadam@hotmail.com
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unless otherwise stated.compliance and adherence of pregnant women to the
iron and folic acid supplementation [11-16].
Anaemia during pregnancy is a major health problem in
Sudan affecting around half of women in some areas; it is
a risk factor for maternal and perinatal morbidity and
mortality [3,8]. Pregnant women are at risk of anaemia re-
gardless of their age or parity [8,17]. However, no pub-
lished data exist on the use of iron-folic acid supplements
in pregnant women in Sudan. Such studies are needed to
generate data for health planners and program managers.
Thus, this study was conducted to investigate the rates
and predictors of iron-folic supplementation during
pregnancy and the effect of the supplement on the
prevalence of anaemia in pregnant women and the inci-
dence of low birth weight (LBW) infants.Methods
This hospital-based cross-sectional study was carried out
between June and August 2012 at Khartoum Hospital,ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Khartoum province serving the local community and re-
ceiving medical referrals from other parts of Sudan.
Women carrying a singleton pregnancy were enrolled
in the study. Each participant provided written, informed
consent. A medical officer used a pre-tested questionnaire
to gather data from each parturient mother on her age,
parity, level of education (illiterate, primary school or sec-
ondary school education and above), antenatal care visits,
occupation (house wife or working mother), gestational
age in weeks, medical diseases (diabetes, hypertension,
urinary tract infections and thyroid problems) use of iron-
folic acid supplements, delivery data including the sex and
the birth weight of the baby. The maternal haemoglobin
level, which is routinely checked for all women admitted
in labor using automated hematology analyzer (Sysmex
KX21N: Sysmex Corporation, Kobe, Japan), was recorded.
The term ‘supplement use’ refers to the use of iron-
folic acid or folic acid only. Combined tablets containing
both supplements are available free of charge as part of
a antenatal care package, which is also free of charge.
Governmental policy recommends the use of folic acid
in early pregnancy (the first trimester) and the combined
tablets that contain iron and folic acid thereafter (in the
second and third trimesters.
A birth weight of less than 2500 g is used as a cut off
limit to define low birth weight (LBW) in this study.
The sample size of 850 women was calculated to have
an 80% power to detect a difference of 5% (5% at α =
0.05) in the proportion of those using the supplement
and those who did not, assuming the true proportion
was 70% and that 10% of women would not be respond.
Data were analyzed using SPSS version 20.0 for Win-
dows (SPSS Inc., Chicago, IL, USA). Mean (SD) and pro-
portions of the variables were compared using student t-
tests and χ2 tests, respectively. The number of women
who used folic acid, or iron or both supplements during
the antenatal period was calculated. Univariate andTable 1 Comparing number (%) of the maternal and infant ch
supplementation to those who didn’t at Khartoum Hospital, S
Variable Used iron-folic acid
(n = 788)
Primiparity 97 (12.4)
Education≥ secondary level 601 (76.3)
Maternal job (employee) 155 (19.7)
Attended antenatal care 751 (95.3)
Urban residence 504 (64.0)
No medical diseases 732 (92.9)
Anaemia 365 (46.3)
Male gender 424 (53.8)
Low birth weight 90 (13.1)multivariate analyses were performed where iron-folic
acid supplementation was the dependent variable and
socio-demographic factors were the independent variables.
All the independent variables in the univariate analysis
were entered in the multivariate one regardless to their
significant. The corrected odds ratio for anaemia and
LBW were analyzed for supplements using logistic regres-
sion models. A P-value <0.05 was considered significant.
Ethical approval for the study was obtained from
Khartoum Teaching Hospital and Sudan Medical Spe-
cialization Board.
Results
During the study, 876 eligible women attended the hos-
pital, of which 856 provided complete data and were in-
cluded in the final analyses. Of these 856 women, 788
(92.1%) used iron-folic acid during the current preg-
nancy, and 65.4% used folic acid in the first trimester. A
significantly higher number of women who used iron-
folic acid were educated, were resident in a town and
had attended antenatal care, Table 1. Of these 856
women who delivered in the hospital, 791 (92.4%)
attended antenatal care and 65 (7.6%) did not attend
antenatal care. The supplement rate was 99.6% (788/
791) and 57.0% (37/65), P < 0.001 among the women
who attended antenatal care and women who had no
antenatal care and delivered in the hospital, respectively.
The women who used iron-folic acid supplements were
significantly older than those who did not (mean age
[SD] 28.3 [6.5] versus 26.4 [7.0] years; P = 0.022).
In the logistic regression analysis, while there was no
association between parity, education level, medical dis-
eases (included diabetes, hypertension, thyroid problems
and urinary tract infections), place of residence (urban
or country) or occupation and use of iron-folic acid sup-
plementation, older age (OR = 3, 1.4–6.3) and use of
antenatal care (14.3, 7.4–27.5) were associated with iron-
folic acid use, Table 2.aracteristics of the group who used iron-folic
udan











Table 2 Univariate and multivariate analyses for predictors of hematinic use among pregnant women at Khartoum,
Sudan
Univariate analysis Multivariate analysis
The variables OR 95% CI P O R 95% CI P
Age > 28.0 year 2.9 1.5-5.3 0.001 3.0 1.4-6.3 0.005
primiparae 1.2 0.5-2.7 0.673 1.2 0.45-3.1 0.72
Education≥ secondary level 1.9 1.1-3.1 0.019 0.92 1.5-4.5 0.73
Urban residence 1.84 1.12-3.0 0.016 1.0 0.55-2.1 0.86
Maternal job (employee) 0.7 0.4-1.5 0. 384 0.81 0.35-1.91 0.63
Attended antenatal care 14.7 8.1-26.4 <0.001 14.3 7.4-27.5 <0.001
No medical diseases 0.6 0.19-2.6 0.421 0.67 0.18-2.5 0.55
Abdullahi et al. BMC Research Notes 2014, 7:498 Page 3 of 4
http://www.biomedcentral.com/1756-0500/7/498Similarly, in further logistic regression analysis, age,
level of education, place of residence and medical dis-
eases were not associated with folic acid use in the first
trimester; whereas parity, attending antenatal care and
employment were associated with folic acid use, Table 3.
Haemoglobin readings (mean [SD] 11.0 [1.1] versus
10.2 [1.4] g/dl; P < 0.001) and birth weight (mean [SD]
3055.8 [545.7] versus 2818.2 [647.1] g, P = 0.001] were
significantly higher in the women who used iron-folic
acid supplements than in those who did not. Likewise
the prevalence of anaemia and LBW infants was higher
among women who did not use the supplement, Table 1.
The women who used iron and folic acid were less likely
to have anaemia (OR = 0.39, CI = 0.2–0.7, P = 0.004) or a
baby with LBW (OR = 0.3, CI = 0.17–0.68, P = 0.002).
Discussion
The main findings of the study were that 92.1% of the
investigated women used iron-folic acid supplements
during pregnancy and 65.4% used folic acid only in the
first trimester of their pregnancy. Older age and use of
antenatal care were associated with iron-folic acid sup-
plementation use. Those women who used iron-folic
acid were at lower risk for anaemia and infants with
LBW. The rate of using iron-folic acid in this study
(92.1%) was higher than the rate reported among pregnantTable 3 Univariate and multivariate analyses for predictors o
women at Khartoum, Sudan
Univariate analysis
The variables OR 95% CI
Age > 28.0 year 1.35 0.86-2.14
primiparae 3.4 1.9-5.9
Education≥ secondary level 1.04 0.75-1.45
Urban residence 0.84 0.66-1.19
Maternal job (employee) 2.37 1.56-3.6
antenatal care 5.7 3.2-10.2
No medical diseases 1.01 0.57-1.76women in Eastern Sudan (81.5%) [17] or other African
countries e.g. Nigeria, Tanzania and Kenya [9,10,18]. The
high rate of iron and folic acid use in the current study
compared with other studies may be because this study
was carried out in a tertiary hospital in the capital of
Sudan, Khartoum. Therefore, these results are not neces-
sarily representative of practice in the community or in
rural areas. In addition, this study found that women who
have attended antenatal care were more likely to use iron-
folic acid supplements or folic acid than those who had
not attended antenatal care. Thus, successful uptake of
iron-folic acid supplementation is linked to the use of
antenatal care during pregnancy [19].
In the current study, in addition to the use of antenatal
care, older women were 3 times as likely to use iron-folic
acid supplementation as younger women and primipara
were 4 times more likely than multipara to use folic acid
in the first trimester. Previous studies showed that older
age, parity and greater levels of education were associated
with taking supplements during pregnancy [10,14]. How-
ever, factors associated with the use of these supplements
may differ depending on setting.
The current study showed that haemoglobin level and
infant birth weight was significantly higher in women
who used iron-folic acid. Intake of iron and folic acid
was associated with a lower risk of anaemia and infantf folic acid use in the first trimester among pregnant
Multivariate analysis
P O R 95% CI P
0.187 1.5 0.93-2.7 0.084
<0.001 3.8 1.9-7.6 <0.001
0.7756 0.67 0.44-1 0.068
0.433 1.1 0.77-1.6 0.546
<0.001 3.9 2.25-6.77 <0.001
<0.001 7.9 4.1-15 <0.001
0.974 1.31 0.67-2.58 0.426
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of folic acid only was not related to LBW of the infant,
and iron supplementation was associated with a lower
risk of infant LBW, once other factors such as body
mass index, obstetric diseases during pregnancy, weight
gain during pregnancy and previous LBW were adjusted
for [20]. In China, Lui et al. have found that iron-folic
acid supplements reduced the incidence of anaemia but
did not influence perinatal mortality or infant outcome
[21]. However, the WHO recommendation for areas
where anaemia is prevalent is that all pregnant women
receive supplements of iron-folic acid in order to pre-
vent anaemia and its maternal and perinatal complica-
tions [5].Conclusion
There was a high rate of iron-folic acid supplementation
use among pregnant women in Khartoum, Sudan, which
was beneficial in preventing anaemia in expectant
mothers and infants of LBW.
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